Seneca Growth Capital VCT Plc (HYG) Ordinary 1p
Sell:8.00p
Buy:15.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:8.00p
Buy:15.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:8.00p
Buy:15.00p
Change:
No change
No change
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The objective of Company has to date been to provide shareholders with an attractive income and capital return by investing its funds in a portfolio of unquoted and AIM/AQSE quoted UK companies which meet the relevant criteria under the VCT Rules. The Company will target well managed businesses with strong leadership, that can demonstrate established and proven concepts, and are seeking an injection of growth capital to support their continued development.
| Security | Weight |
|---|---|
| Scancell Holdings plc Ord GBP0.001 | 57.83% |
| Arecor Therapeutics plc ORD GBP0.01 | 29.60% |
| Insense Limited | 4.99% |
| Fuel 3d Technologies Limited | 4.86% |
| Sector | Weight |
|---|---|
| Healthcare | 87.43% |
| Country | Weight |
|---|---|
| United Kingdom | 87.43% |
Fee Structure
The company is managed by the Board of Directors. A performance fee of 10% is payable if dividends and capital distributions exceed the sum of 80GBX per share, which is the gross subscription of 100GBX less 20GBX income tax deemed by the Board.
Dividend Policy
Dividends will be paid by the Registrar on behalf of the Company. The current policy of Board with regard to dividends will be to return funds to shareholders as soon as practical following any significant realisation.The Company pays dividend semi-annually.
ASSET SPLIT
Trust Manager
Not Disclosed
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Ian DigheChairman, Mary Cordeiro, Richard Manley, Alex Clarkson
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.